METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AND 5-FLUOROURACIL IN MICE BEARING ASCITES SARCOMA 180IIGO M; KURETANI K; HOSHI A et al.1981; J. NATL. CANCER INST.; ISSN 0027-8874; USA; DA. 1981; VOL. 66; NO 2; PP. 345-349; BIBL. 13 REF.Article

EFFECT AND TOXICITY OF COMBINATION TREATMENT INCLUDING CYCLOCYTIDINE OR CYTOSINE ARABINOSIDE IN "L1210 AND SARCOMA-180 SYSTEMSHOSHI A; KANZAWA F; IIGO M et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 5; PP. 539-546; BIBL. 12 REF.Article

L'EFFET DU MOLYBDENE SUR LA REDUCTION DE L'OXYDE-1 DE NITRO-4 QUINOLEINEMORITA I; IIGO M; FUKINO H et al.1975; YAKUGAKU ZASSHI, J. PHARM. SOC. JAP.; JAP.; DA. 1975; VOL. 95; NO 8; PP. 954-958; ABS. ANGL.; BIBL. 14 REF.Article

Circadian rhythms of locomotor activity in the goldfish Carassius auratusIIGO, M; TABATA, M.Physiology & behavior. 1996, Vol 60, Num 3, pp 775-781, issn 0031-9384Article

Potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine by guanosine-5'-monophosphateIIGO, M; HOSHI, A.Journal of pharmacobio-dynamics. 1984, Vol 7, Num 1, pp 67-69, issn 0386-846XArticle

ANTITUMOR ACTIVITY OF 1-ACYLOXYMETHYL DERIVATIVES OF 5-FLUOROURACIL AGAINST L1210 LEUKEMIAHOSHI A; INOMATA M; KANZAWA F et al.1982; J. PHARMACOBIO-DYN; ISSN 0386-846X; JPN; DA. 1982; VOL. 5; NO 3; PP. 208-212; BIBL. 6 REF.Article

EFFECT OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL ON SPONTANEOUS MAMMARY ADENOCARCINOMA OF MICETOKUZEN R; IIGO M; HOSHI A et al.1980; GANN; ISSN 0016-450X; JPN; DA. 1980; VOL. 71; NO 5; PP. 724-728; BIBL. 11 REF.Article

METABOLIC FATE OF 1-HEXYLCARBAMOYL-5-FLUOROURACIL AFTER ORAL ADMINISTRATION IN MICEIIGO M; NAKAMURA A; KURETANI K et al.1980; XENOBIOTICA; ISSN 0049-8254; GBR; DA. 1980; VOL. 10; NO 11; PP. 847-854; BIBL. 8 REF.Article

ANTITUMOR ACTIVITY OF N-HETEROCYCLIC CARBOXALDEHYDE THIOSEMICARBAZONE DERIVATIVES.IIGO M; HOSHI A; KURETANI K et al.1977; GANN; JAP.; DA. 1977; VOL. 68; NO 2; PP. 221-225; BIBL. 5 REF.Article

DISTRIBUTION OF CYCLOCYTIDINE IN TISSUES.HOSHI A; IIGO M; KURETANI K et al.1975; CHEM. PHARM. BULL.; JAP.; DA. 1975; VOL. 23; NO 4; PP. 725-728; BIBL. 8 REF.Article

ANTITUMOR ACTIVITY OF CARBAMOYL DERIVATIVES OF 5-FLUOROURACIL BY ORAL ADMINISTRATIONHOSHI A; IIGO M; YOSHIDA M et al.1975; GANN; JAP.; DA. 1975; VOL. 66; NO 6; PP. 673-674; BIBL. 2 REF.Article

Mechanism of potentiation of antitumor activity of 5-fluorouracil against adenocarcinoma 755 by L-cysteineIIGO, M; HOSHI, A.Biochemical pharmacology. 1986, Vol 35, Num 5, pp 727-730, issn 0006-2952Article

ANTITUMOR ACTIVITY OF 1-ALKOXYCARBONYLALKYLCARBAMOYL-5-FLUOROURACIL DERIVATIVES BY ORAL ADMINISTRATIONIIGO M; HOSHI A; INOMATA M et al.1981; J. PHARMACOBIO-DYN.; ISSN 0386-846X; JPN; DA. 1981; VOL. 4; NO 3; PP. 203-210; BIBL. 11 REF.Article

ANTINEOPLASTIC EFFECT OF ORALLY ADMINISTERED 1-ALKYL CARBAMOYL DERIVATIVES OF 5-FLUOROURACIL ON SC IMPLANTED LEWIS LUNG CARCINOMA AND B16 MELANOMAIIGO M; HOSHI A; NAKAMURA A et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 1895-1899; BIBL. 7 REF.Article

INTERACTION OF ANTITUMOR AGENTS INCLUDING CARBOQUONE IN SARCOMA-180 SYSTEM.IIGO M; NAKAMURA A; HOSHI A et al.1976; GANN; JAP.; DA. 1976; VOL. 67; NO 5; PP. 641-644; BIBL. 10 REF.Article

ANTITUMOR ACTIVITY OF BENZOYL AND BENZENESULFONYL DERIVATIVES OF 5-FLUOROURACILHOSHI A; IIGO M; NAKAMURA N et al.1974; GANN; JAP.; DA. 1974; VOL. 65; NO 5; PP. 463Article

Markedly induced asialoGM1⁺CD8⁺ T cell production and enhancement of antimetastatic activity by interferon β with folic or folinic acidIIGO, M; MORIYAMA, M; SUZUKI, I et al.Cancer immunology and immunotherapy. 1997, Vol 44, Num 2, pp 65-69, issn 0340-7004Article

Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in miceIIGO, M; NAKAJIMA, Y; HOSHI, A et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 6, pp 773-777, issn 0277-5379Article

Characteristics of the inhibitory effect of mitoxantrone and pirarubicin on lung metastases of colon carcinoma 26IIGO, M; SHIMAMURA, M; SAGAWA, K et al.Japanese journal of cancer research. 1995, Vol 86, Num 9, pp 867-872, issn 0910-5050Article

Synergistic antitumor effects of carboplatin and interferons on hepatic metastases of colon carcinoma 26 and M5076 reticulum cell sarcomaIIGO, M; SHIMIZU, I; SAGAWA, K et al.Japanese journal of cancer research. 1993, Vol 84, Num 7, pp 794-799, issn 0910-5050Article

Effects of anthracycline derivatives on hepatic neoplastic nodules of Lewis lung carcinoma and colon adenocarcinoma 26IIGO, M; NISHIKATA, K; NAKAJIMA, Y et al.British journal of cancer. 1991, Vol 63, Num 3, pp 363-366, issn 0007-0920Article

Biochemical studies on the antitumor activity of platinum and ruthenium complexesSAKAI, K; FUKATA, Y; YAMANE, Y et al.Journal of pharmacobio-dynamics. 1990, Vol 13, Num 1, issn 0386-846X, p. s-22Conference Paper

Elevation of plasma levels of fluorinated pyrimidines by guanosine 5'-monophosphateIIGO, M; YAMAIZUMI, Z; NISHIMURA, S et al.Cancer chemotherapy and pharmacology. 1987, Vol 20, Num 1, pp 1-4, issn 0344-5704Article

Potentiation of the chemotherapeutic action of 5'-deoxy-5-fluorouridine in combination with guanosine and related compoundsIIGO, M; MIWA, M; ISHITSUKA, H et al.Cancer chemotherapy and pharmacology. 1987, Vol 19, Num 1, pp 61-64, issn 0344-5704Article

ANTITUMOR ACTIVITY OF BERBERRUBINE DERIVATIVES.HOSHI A; IKEKAWA T; IKEDA Y et al.1976; GANN; JAP.; DA. 1976; VOL. 67; NO 2; PP. 321-325; BIBL. 11 REF.Article